CAPNS2 antibody
Principal name
CAPNS2 antibody
Alternative names for CAPNS2 antibody
Calpain small subunit 2, CSS2, Calcium-dependent protease small subunit 2
Ncbi ID
9606, NM_032330, NP_115706, NP_115706.1, NP_081388.1, NM_027112
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of CAPNS2 antibody
- Kit Component:
- - KN302516G1, Capns2 gRNA vector 1 in pCas-Guide vector
- KN302516G2, Capns2 gRNA vector 2 in pCas-Guide vector
- KN302516D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human Fetal liver; WB Suggested Anti-CAPNS2 Antibody. . Titration: 1.0 ug/ml. . Positive Control: Fetal Liver; CAPNS2 antibody - N-terminal region (ARP60408_P050) in Human Fetal liver cells using Western Blot
WB Suggested Anti-CAPNS2 Antibody; Titration: 1.0 ug/ml; Positive Control: Fetal Liver
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303338 | CAPNS2 |
||||
| Recombinant protein of human calpain, small subunit 2 (CAPNS2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY410206 | CAPNS2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR219341L2V | Lenti ORF particles, Capns2 (GFP-tagged) - Mouse calpain, small subunit 2 (Capns2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,050.00
|
|
| OriGene Technologies, Inc. | ||
| MR219341L1V | Lenti ORF particles, Capns2 (Myc-DDK-tagged) - Mouse calpain, small subunit 2 (Capns2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||